Bradshaw Start free trial

Omass Therapeutics Limited

Active

Data to 4 Nov 2026, 01:59

Company number
10028228
Sector
Health and life sciences
SIC group
Life sciences and health
Region
South East (Oxford)
Incorporated
26 Feb 2016
SIC code
72110
Trading name
Not found
Website
Not found

Omass Therapeutics Limited has 2 priced rounds on record from share allotment filings at Companies House. The latest was allotted on 25 Sep 2026, raised £40.0m, and was filed on 2 Oct 2026. Data to 3 Nov 2026.

Companies with significant control: Syncona Limited (25 to 50%). From the PSC register.

2

Priced rounds

Allotted Jul 2024 to Sep 2026

£74.2m

Cash raised in those rounds

Sum of sterling cash raised in each round, as filed

25 Sep 2026

Latest round allotted

Filed 2 Oct 2026

Jump to

Funding rounds

Priced equity rounds read from share allotment filings at Companies House, newest first.

Edit columns
Funding rounds for Omass Therapeutics Limited
Allotted First filed Cash raised Filing
25 Sep 2026to 30 Sep 2026Latest 2 Oct 2026 £40.0m Open filing
31 Jul 2024 7 Aug 2024 £34.2m Open filing
Price per share, post-money and step-ups for these 2 rounds are in the full company page.

Companies with significant control

Companies with significant control over Omass Therapeutics Limited, from the register of people with significant control. A company can have control without holding shares. Individuals are not shown on public pages.

Edit columns
Companies with significant control
Holder Notified Ceased Shares held
Oxford Sciences Innovation PLC 6 Apr 2016 11 Sep 2018 25 to 50%
Oxford Science Enterprises Holdings II Limited 11 Sep 2018 30 Sep 2026 25 to 50%
Syncona Limited 11 Sep 2018 n/a 25 to 50%
Oxford Science Enterprises Holdings II Limited 11 Sep 2018 11 Sep 2018 25 to 50%

From the PSC register.

Filings

The latest 6 capital filings other than share allotments (SH01), which are listed under Funding rounds. 55 share filings (SH01, SH02, SH03, SH06 and SH08) have been read for this company.

Edit columns
Latest capital filings
Date Filing Document
14 Oct 2026 Purchase of own shares (SH03) Open at Companies House
9 Oct 2026 Resolution Open at Companies House
9 Oct 2026 Memorandum and articles (MA) Open at Companies House
23 Sep 2026 Cancellation of shares (SH06) Open at Companies House
14 Jan 2026 Change of share class name (SH08) Open at Companies House
3 Dec 2025 Change of share class name (SH08) Open at Companies House

Documents open at Companies House. Bradshaw does not store or re-host them.

About this page

This page shows public register data for Omass Therapeutics Limited. Figures come from filings at Companies House; Bradshaw links to each filing and does not host copies. To correct or object to data about you, use the data request form.

Last updated 3 Nov 2026